摘要
目的:探讨瑞舒伐他汀预处理对小鼠心肌缺血/再灌注后炎症因子的影响及其可能的心肌保护机制。方法:C57小鼠72只随机分为3组:假手术组(Sham组)、心肌缺血/再灌注组(MI/R组)、心肌缺血/再灌注+瑞舒伐他汀预处理组(MI/R+R组);建立小鼠MI/R模型;ELISA法检测血清高敏C反应蛋白(hs-CRP)和肿瘤坏死因子-α(TNF-α)的含量,Evansblue/TTC染色测定心肌梗死面积,TUNEL染色检测心肌细胞凋亡。结果:MI/R+R组的hs-CRP和TNF-α含量明显低于MI/R组(P<0.01)。MI/R+R组与MI/R组相比,心肌梗死面积明显减少(P<0.05),心肌细胞凋亡显著减轻(P<0.05)。结论:瑞舒伐他汀可能通过减少炎症因子合成或释放,进而抑制心肌细胞凋亡,减轻小鼠心肌缺血/再灌注损伤。
Objective: To study the effect of inflammatory factor and the eardiopro teetive mechanism on rosuvastatin pretreatment of my- oeardial ischemia/reperiusion in mice. Methods: Seventy-two male C57 mice were randomly divided into three groups: sham group(group Sham), myocardial isehemia/reperfusion group(group Ml/R)and rosuvastatin pretreatment group(group MI/R+R). Mouse MI/R model was es- tablished. Concentrations of serum high sensitivity C-reactive protein (hs-CRP) and tumor necrosis factor alpha (TNF-a) were measured by ELISA. Myocardial tissue samples were stained with TTC to detect the size of myocardial infarction. Myocardial apoptosis were observed hy TUNEL stained. Results: Concentrations of sermn hs-CRP and TNF-c~ were significantly lower in group MI/R+R than in group MI/R (P〈 0.01). Myocardial infarctionsize was smaller(P〈0.05) and myocardial apoptosis was reduced(P〈0.05) in group MI/R+R. Conclusion: Rosu- vastatin pretreatment protects myocardium against I/R injury and inhibites apoptosis possibly by reducing the synthesis or release of inflam- mation factors.
出处
《天津医科大学学报》
2013年第5期380-382,F0003,共4页
Journal of Tianjin Medical University
关键词
瑞舒伐他汀
心肌缺血/再灌注
高敏C反应蛋白
肿瘤坏死因子-Α
小鼠
rosuvastatin
myocardial ischemia/repeffusion
high sensitivity C-reactive protein
tumor necrosis faetor alpha
mouse